INTEGRA LIFESCIENCES HOLDINGS CORP Payments to Acquire in Process Research and Development
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Payments to Acquire in Process Research and Development of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-10-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2023-10-25
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for the quarter ending 2023-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for the quarter ending 2023-06-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for the quarter ending 2022-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for fiscal 2019 was $65.00M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for fiscal 2018 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire in process research and development for fiscal 2017 was $0.00.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 6 month | Payments to Acquire in Process Research and Development 9 month | Payments to Acquire in Process Research and Development 9 month as first filed | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $0.00 derived: sum of 2 quarters · filed 2023-10-25 | $0.00 10-Q · filed 2023-10-25 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $0.00 10-Q · filed 2023-07-27 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-04-26 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $0.00 derived: sum of 2 quarters · filed 2023-10-25 | $4.74M 10-Q · filed 2023-10-25 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $4.74M 10-Q · filed 2023-07-27 | |||
| 2022-03-31 | $4.74M 10-Q · filed 2023-04-26 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $0.00 derived: sum of 2 quarters · filed 2022-10-26 | $0.00 10-Q · filed 2022-10-26 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $0.00 10-Q · filed 2022-07-27 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-04-27 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $5.00M 10-Q · filed 2021-11-02 | $0.00 10-Q · filed 2020-10-29 | $5.00M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $5.00M 10-Q · filed 2021-07-29 | $5.00M derived: sum of 3 quarters · filed 2021-07-29 | $70.00M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | $5.00M 10-Q · filed 2021-04-29 | $5.00M derived: sum of 2 quarters · filed 2021-04-29 | $70.00M derived: sum of 3 quarters · filed 2021-04-29 | $70.00M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $65.00M derived: sum of 2 quarters · filed 2020-10-29 | $65.00M derived: sum of 3 quarters · filed 2020-10-29 | $65.00M 10-K · filed 2020-02-21 | |
| 2019-09-30 | $65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $65.00M derived: sum of 2 quarters · filed 2020-10-29 | $65.00M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-02-21 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |